⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Auriclosene SCHEMBL1537304 | 0.98 | — | — | |
| Auriclosene SCHEMBL2321981 | 0.84 | — | — | |
| SCHEMBL2866753 | 0.83 | — | — | |
| SCHEMBL3379316 | 0.83 | CYP1A2 (0.32) | — | |
| SCHEMBL2870636 | 0.82 | PTGS1 (0.31) | — | |
| Tetrabuthylammonium SCHEMBL4167461 | 0.82 | SLC22A1 (0.40) | — | |
| Auriclosene SCHEMBL1537297 | 0.82 | TP53 (0.30) | — | |
| SCHEMBL20893589 | 0.81 | — | — | |
| SCHEMBL27271998 | 0.78 | — | — | |
| SCHEMBL2871032 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11712436-B2 | Theranostic test for antifungal treatment of inflammatory diseases | CORNELL UNIVERSITY (US) | 2023-08-01 | — | — | US | claimed |
| CN-116133657-A | New compositions and methods for treating covd-19 disease | 4活性生物科技公司 | 2023-05-16 | — | — | CN | claimed |
| US-20170360880-A1 | ANTI-AIDS COCKTAIL CONSISTING OF AN ANTI-TUMORAL COMPOUND, A P-GLYCOPROTEIN INHIBITOR, AND AN ANTI-VIRAL AGENT | ARION TECNOLOGIA BRAZIL - GESTÄO DE ATIVOS S/A (BR) | 2017-12-21 | — | — | US | claimed |
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| EP-2531026-A1 | POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2012-12-12 | — | — | EP | claimed |
| US-20120282351-A1 | System and Method for The Prevention of Bacterial and Fungal Infections Including Urinary Tract Infections (UTI) Using N-Halogenated Amino Acids | NOVABAY PHARMACEUTICALS, INC. | 2012-11-08 | — | — | US | claimed |
| WO-2011097324-A1 | POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | WO | claimed |
| US-20110190392-A1 | Polysaccharide Based Antimicrobial Formulations | NOVABAY PHARMACEUTICALS, INC. | 2011-08-04 | — | — | US | claimed |
| US-20110151025-A1 | Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections | NOVABAY PHARMACEUTICALS, INC. | 2011-06-23 | — | — | US | claimed |
| US-20110091570-A1 | Compositions and Devices for Antisepsis and Anticoagulation | GOTTARDI WALDEMAR | 2011-04-21 | — | — | US | claimed |
| EP-1896001-A1 | N-HALOGENATED AMINO ACIDS AND N, N-DIHALOGENATED AMINO ACIDS IN COMBINATION WITH HYPOHALOUS ACIDS | Novabay Pharmaceuticals, Inc. (US) | 2008-03-12 | — | — | EP | claimed |
| US-20070292489-A1 | METHOD FOR TREATMENT OF WOUND TREATMENT USING AGANOCIDES | NOVABAY PHARMACEUTICALS, INC. | 2007-12-20 | — | — | US | claimed |
| EP-1656095-A4 | N,N-DIHALOGENATED AMINO ACIDS AND DERIVATIVES | NOVACAL PHARMACEUTICALS INC (US) | 2007-11-28 | — | — | EP | claimed |
| US-20070244449-A1 | System and method for the prevention of bacterial and fungal infections including Urinary Tract Infections (UTI) using N-halogenated amino acids | NOVACAL PHARMACEUTICALS, INC. | 2007-10-18 | — | — | US | claimed |
| WO-2007044559-A1 | SYSTEM AND METHOD FOR THE PREVENTION OF BACTERIAL AND FUNGAL INFECTIONS INCLUDING URINARY TRACT INFECTIONS (UTI) USING N-HALOGENATED AMINO ACIDS | NOVABAY PHARMACEUTICALS, INC. (US) | 2007-04-19 | — | — | WO | claimed |
| US-20060247209-A1 | N-halogenated amino acids, N,N-dihalogenated amino acids and derivatives; compositions and methods of using them | NOVABAY PHARMACEUTICALS, INC. | 2006-11-02 | — | — | US | claimed |
| WO-2006081392-A1 | N-HALOGENATED AMINO ACIDS AND N, N-DIHALOGENATED AMINO ACIDS IN COMBINATION WITH HYPOHALOUS ACIDS | NOVABAY PHARMACEUTICALS, INC. (US) | 2006-08-03 | — | — | WO | claimed |
| EP-1656095-A2 | N,N-DIHALOGENATED AMINO ACIDS AND DERIVATIVES | NovaCal Pharmaceuticals, Inc. (US) | 2006-05-17 | — | — | EP | claimed |
| US-20050065115-A1 | N,N-dihalogenated amino acids and derivatives | NOVABAY PHARMACEUTICALS, INC. | 2005-03-24 | — | — | US | claimed |
| WO-2005020896-A2 | N,N-DIHALOGENATED AMINO ACIDS AND DERIVATIVES | NOVACAL PHARMACEUTICALS, INC. (US) | 2005-03-10 | — | — | WO | claimed |